Timolaos Rizos1, Anika Quilitzsch1, Otto Busse1, Karl Georg Haeusler1, Matthias Endres1, Peter Heuschmann1, Roland Veltkamp2. 1. From the Department of Neurology, University of Heidelberg, Heidelberg, Germany (T.R., R.V.); Institute of Clinical Epidemiology and Biometry (A.Q., P.H.), and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; German Stroke Society: Deutsche Schlaganfall-Gesellschaft (DSG), Berlin, Germany (O.B.); Department of Neurology and Center for Stroke Research Berlin-Charité (K.G.H., M.E.), German Center for Cardiovascular Research (DZHK) (M.E.), and German Center for Neurodegenerative Diseases (DZNE)-Charité (M.E.), Universitätsmedizin Berlin, Berlin, Germany; Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany (P.H.); and Department of Stroke Medicine, Imperial College London, London, United Kingdom (R.V.). 2. From the Department of Neurology, University of Heidelberg, Heidelberg, Germany (T.R., R.V.); Institute of Clinical Epidemiology and Biometry (A.Q., P.H.), and Comprehensive Heart Failure Center (P.H.), University of Würzburg, Würzburg, Germany; German Stroke Society: Deutsche Schlaganfall-Gesellschaft (DSG), Berlin, Germany (O.B.); Department of Neurology and Center for Stroke Research Berlin-Charité (K.G.H., M.E.), German Center for Cardiovascular Research (DZHK) (M.E.), and German Center for Neurodegenerative Diseases (DZNE)-Charité (M.E.), Universitätsmedizin Berlin, Berlin, Germany; Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany (P.H.); and Department of Stroke Medicine, Imperial College London, London, United Kingdom (R.V.). roland.veltkamp@med.uni-heidelberg.de.
Abstract
BACKGROUND AND PURPOSE: Multiple methods to detect paroxysmal atrial fibrillation (pAF) in patients with acute stroke are available. However, it is unknown which approaches are currently used in clinical routine and guidelines remain vague to the extent of cardiac monitoring. We characterize diagnostic efforts for pAF detection on German stroke units (SU). METHODS: A standardized anonymous questionnaire was sent to all clinical leads of certified SUs in Germany. The questionnaire focused on basic characteristics of SUs, procedures to detect AF, and estimates on AF detection. RESULTS: One hundred seventy-nine SU leads participated (response rate 71.6%). All patients undergo continuous bedside ECG monitoring. A percentage of 77.6 SUs initiate additional 24-hour Holter ECG in >50% of patients without known AF. Patients with transient ischemic attack are monitored significantly shorter than patients with ischemic stroke. Independent of SU type or size, 67.6% of leads assumed to fail detecting pAF in 5% to 20% of patients. In cryptogenic stroke, additional ECG monitoring is recommended by 90.2% but only 13.8% of SUs perform routine ECG follow-up visits. The use of implanted event recorders is low (1-10 patients/y by 60.7% of SUs; 28.1%: no use). A percentage of 83.9 do not use external event recorders. CONCLUSIONS: Our survey demonstrates substantial heterogeneity among German SUs on diagnostic work-up for pAF. Future prospective multicenter studies should systematically evaluate the impact of different methods to uncover pAF.
BACKGROUND AND PURPOSE: Multiple methods to detect paroxysmal atrial fibrillation (pAF) in patients with acute stroke are available. However, it is unknown which approaches are currently used in clinical routine and guidelines remain vague to the extent of cardiac monitoring. We characterize diagnostic efforts for pAF detection on German stroke units (SU). METHODS: A standardized anonymous questionnaire was sent to all clinical leads of certified SUs in Germany. The questionnaire focused on basic characteristics of SUs, procedures to detect AF, and estimates on AF detection. RESULTS: One hundred seventy-nine SU leads participated (response rate 71.6%). All patients undergo continuous bedside ECG monitoring. A percentage of 77.6 SUs initiate additional 24-hour Holter ECG in >50% of patients without known AF. Patients with transient ischemic attack are monitored significantly shorter than patients with ischemic stroke. Independent of SU type or size, 67.6% of leads assumed to fail detecting pAF in 5% to 20% of patients. In cryptogenic stroke, additional ECG monitoring is recommended by 90.2% but only 13.8% of SUs perform routine ECG follow-up visits. The use of implanted event recorders is low (1-10 patients/y by 60.7% of SUs; 28.1%: no use). A percentage of 83.9 do not use external event recorders. CONCLUSIONS: Our survey demonstrates substantial heterogeneity among German SUs on diagnostic work-up for pAF. Future prospective multicenter studies should systematically evaluate the impact of different methods to uncover pAF.
Authors: Karl Georg Haeusler; Klaus Gröschel; Martin Köhrmann; Stefan D Anker; Johannes Brachmann; Michael Böhm; Hans-Christoph Diener; Wolfram Doehner; Matthias Endres; Christian Gerloff; Hagen B Huttner; Manfred Kaps; Paulus Kirchhof; Darius Günther Nabavi; Christian H Nolte; Waltraud Pfeilschifter; Burkert Pieske; Sven Poli; Wolf Rüdiger Schäbitz; Götz Thomalla; Roland Veltkamp; Thorsten Steiner; Ulrich Laufs; Joachim Röther; Rolf Wachter; Renate Schnabel Journal: Clin Res Cardiol Date: 2018-04-27 Impact factor: 5.460
Authors: Olivia Geraghty; Eleni Korompoki; Filippos T Filippidis; Anthony Rudd; Roland Veltkamp Journal: BMJ Open Date: 2016-11-10 Impact factor: 2.692
Authors: Karl Georg Haeusler; Ulrike Grittner; Jochen B Fiebach; Matthias Endres; Thomas Krause; Christian H Nolte Journal: BMC Neurol Date: 2015-10-22 Impact factor: 2.474